| Literature DB >> 34942517 |
Qianhui Zhao1, Wenhui Xue1, Shuang Zhang1, Yu Guo1, Yurong Li1, Xianjun Wu1, Shuying Huo2, Yong Li3, Chenyao Li3.
Abstract
The objective of this experimental study was to examine the effects of the Chinese herbal medicines Patchouli and Elsholtzia on the follicular granulosa cells of hens undergoing heat stress conditions. In the current investigation, hen follicular granulosa cells were isolated from the prehierarchical follicles of layer hens and then cultured in-vitro. The cells were randomly divided into the 6 groups. Following the completion of this study's experiments using different heat stress and medicinal treatments, the cell activities of each group were measured using an MTT method. The levels of the heat shock protein 70 (HSP70) were detected using ELISA. The expressions of the steroidogenic acute regulatory protein (StAR) mRNA; cytochrome P450 family 11, subfamily A, member 1 (CYP11A1) mRNA; proliferating cell nuclear antigen (PCNA) mRNA; and the follicle stimulating hormone receptor (FSHR) were detected using the real-time quantitative polymerase chain reactions. The concentration levels of estrogen and progesterone in the cell supernatant of each group were measured using ELISA. The results showed that cell activity had significantly decreased following the heat stress treatments at 43℃, 44℃, and 45℃ (P < 0.01), respectively. Meanwhile, cell activities observed in Patchouli and Elsholtzia were found to be much better than those of heat stress group (P < 0.05). In addition, the expression levels of HSP70 in the follicular granulosa cells of Patchouli and Elsholtzia groups were lower than those of heat stress group. Patchouli and Elsholtzia can maintain expressions of the receptor at 43℃. This study determined that the estrogen and progesterone in the supernatant fluid of Patchouli and Elsholtzia were higher than those observed in heat stress. Therefore, the results obtained in this study indicated that the Patchouli and Elsholtzia treatments administered prior the heat stress experiments had successfully protected the follicular granulosa cells from heat damages while maintaining the normal secretory functions of the granulosa cells.Entities:
Keywords: Elsholtzia; Patchouli; follicular granulosa cell; heat stress treatment; secretory function
Mesh:
Substances:
Year: 2021 PMID: 34942517 PMCID: PMC8695352 DOI: 10.1016/j.psj.2021.101306
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Follicular granulosa cell grouping table.
| Groups | Treatment measures |
|---|---|
| CON1 | heat stress or herbal medicinal treatments |
| CON2 | heat treatments and without drug treatments |
| EXP1 | |
| EXP2 | |
| EXP3 | |
| EXP4 |
Note: There were 4 repeating groups established in each treatment group of the 6 examined groups.
Primers used for detection of proliferating cell nuclear antigen (PCNA), steroidogenic acute regulatory protein (StAR), cytochrome P450 family 11 subfamily A member 1 (CYP11A1), and follicle stimulating hormone receptor (FSHR) gene by real-time quantitative polymerase chain reaction.
| Gene | Primer sequences | Ampliconsize (bp) | Annealingtemperature (°C) | Accessionnumber |
|---|---|---|---|---|
| GAPDH-F | ACGTCGCACTGGATTTCGAG | 82 | 60 | NM_204305 |
| GAPDH-R | TGTCAGCAATGCCAGGGTAC | |||
| PCNA-F | GCAGATGTTCCTCTCGTTGTGGAG | 95 | 60 | NM_204170.2 |
| PCNA-R | GAGCCTTCCTGCTGGTCTTCAATC | |||
| StAR-F | CGCTGCCATCTCCTACCAACAC | 197 | 60 | NM_204686.2 |
| StAR-R | AGGACATCTCCATCTCGCTGAAGG | |||
| CYP11A1-F | CCGCCACCTCAACACCAAGAC | 157 | 60 | NM_001001756.1 |
| CYP11A1-R | CACAAGGAGGCTGAAGAGGATGC | |||
| FSHR-F | AAGAGCGAGGTCTACATACA | 414 | 52 | XM_025148544.1 |
| FSHR-R | GTGGTGTTCCCAGTGATAG |
Refers to the forward primer and reverse primer glyceraldehyde phosphate dehydrogenase (GAPDH, a housekeeping gene as control for normalization).
Indicates the forward primer and reverse primer of PCNA.
Indicates the forward primer and reverse primer of StAR.
Indicates the forward primer and reverse primer of CYP11A1.
Indicates the forward primer and reverse primer of FSHR.
Viability (OD) of follicular granulosa cells of each group under different stress temperature.
| Stress temperature | |||
|---|---|---|---|
| Groups | 43℃ | 44℃ | 45℃ |
| CON1 | 1.73 ± 0.14Aa | 1.77 ± 0.20Aa | 1.81 ± 0.22Aa |
| CON2 | 1.10 ± 0.13Bb | 1.21 ± 0.12Bb | 1.37 ± 0.18Bb |
| EXP1 | 1.82 ± 0.22Aa | 1.68 ± 0.04Aa | 1.55 ± 0.16Bc |
| EXP2 | 1.36 ± 0.16Bc | 1.36 ± 0.08Bb | 1.37 ± 0.20Bb |
| EXP3 | 1.59 ± 0.24Bc | 1.58 ± 0.07Bc | 1.42 ± 0.09Bb |
| EXP4 | 1.43 ± 0.10Bc | 1.38 ± 0.07Bb | 1.39 ± 0.15Bb |
No a,b,c Indicates significant differences (P < 0.05), A,B,C means extremely significant differences (P < 0.01).
Control group without heat stress or medicinal treatments.
Control group with heat treatments and without drug treatments.
Experimental group with Patchouli additives prior to heat stress.
Experimental group with Patchouli treatments following heat stress.
Experimental group with Elsholtzia additives prior to heat stress.
Experimental group with Elsholtzia treatments following heat stress.
Figure 1The relation curves of heat shock protein 70 (HSP70) concentration and optical density in follicular granulosa cells. The standard curves of HSP70 in follicular granulosa cells were drawn with different concentrations of HSP70 as standard substances, and the absorbance of HSP70 was determined at 450 nm.
Figure 2Heat shock protein 70 (HSP70) of follicular granulosa cells in different groups after heat treatment at 43℃. No a, b, cIndicates significant differences (P < 0.05), A, B, C means extremely significant differences (P < 0.01). Control Group 1 (CON1) without heat stress or herbal medicinal treatments; Control Group 2 (CON2) with heat treatments and without drug treatments; Experimental Group 1 (EXP1) with Patchouli additives prior to heat stress; Experimental Group 2 (EXP2) with Patchouli treatments following heat stress; Experimental Group 3 (EXP3) with Elsholtzia additives prior to heat stress; and Experimental Group 4 (EXP4) with Elsholtzia treatments following heat stress.
Expression of proliferating cell nuclear antigen (PCNA), steroidogenic acute regulatory protein (StAR), and cytochrome P450 family 11 subfamily A member 1 (CYP11A1) mRNA in each group after heat treatment at 43 ℃.
| Gene | |||
|---|---|---|---|
| Groups | PCNA | StAR | CYP11A1 |
| CON1 | 1.81 ± 0.17Aa | 1.90 ± 0.32Aa | 1.85 ± 0.28Aa |
| CON2 | 1.00 ± 0.20Bb | 1.25 ± 0.22B | 0.81 ± 0.09B |
| EXP1 | 3.36 ± 0.02C | 2.67 ± 0.26C | 2.47 ± 0.24C |
| EXP2 | 1.53 ± 0.11Bc | 1.63 ± 0.16Aa | 1.37 ± 0.29Ab |
| EXP3 | 2.30 ± 0.17Ab | 2.26 ± 0.13Ac | 1.96 ± 0.04Aa |
| EXP4 | 1.74 ± 0.25Aa | 2.04 ± 0.03Aa | 1.63 ± 0.28Ac |
No a,b,c Indicates significant differences (P < 0.05), A,B,C means extremely significant differences (P < 0.01).
Control group without heat stress or medicinal treatments.
Control group with heat treatments and without drug treatments.
Experimental group with Patchouli additives prior to heat stress.
Experimental group with Patchouli treatments following heat stress.
Experimental group with Elsholtzia additives prior to heat stress.
Experimental group with Elsholtzia treatments following heat stress.
Figure 3Expression of follicle stimulating hormone receptor (FSHR) mRNA in each group after heat treatment at 43℃. No a, b, cIndicates significant differences (P < 0.05), A, B, C means extremely significant differences (P < 0.01). Control Group 1 (CON1) without heat stress or herbal medicinal treatments; Control Group 2 (CON2) with heat treatments and without drug treatments; Experimental Group 1 (EXP1) with Patchouli additives prior to heat stress; Experimental Group 2 (EXP2) with Patchouli treatments following heat stress; Experimental Group 3 (EXP3) with Elsholtzia additives prior to heat stress; and Experimental Group 4 (EXP4) with Elsholtzia treatments following heat stress.
Concentration of estrogen (E2) and progesterone (P4) in supernatant fluid of each group after heat treatment at 43℃.
| Hormone | ||
|---|---|---|
| Groups | E2 | P4 |
| CON1 | 193.5 ± 29.2Aa | 481.4 ± 19.1Aa |
| CON2 | 67.5 ± 16.7Bb | 280.1 ± 26.5Bb |
| EXP1 | 132.4 ± 11.1Ac | 347.7 ± 27.0Bc |
| EXP2 | 68.9 ± 0.8Bb | 290.3 ± 17.7Bb |
| EXP3 | 90.2 ± 0.3Bb | 319.8 ± 19.9Bc |
| EXP4 | 69.7 ± 5.9Bb | 295.2 ± 23.3Bb |
No a,b,c Indicates significant differences (P < 0.05), A,B,C means extremely significant differences (P < 0.01).
Control group without heat stress or medicinal treatments.
Control group with heat treatments and without drug treatments.
Experimental group with Patchouli additives prior to heat stress.
Experimental group with Patchouli treatments following heat stress.
Experimental group with Elsholtzia additives prior to heat stress.
Experimental group with Elsholtzia treatments following heat stress.